相关实验视频
Updated: Jul 21, 2025
06:13
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
21.5K
休克状态:当代血管压缩剂和内的使用心脏性休克
Jason E Bloom1,2,3, William Chan1,2, David M Kaye1,2
1Department of Cardiology Alfred Health Melbourne Australia.
Journal of the American Heart Association
|July 25, 2023
概括
心脏性休克需要迅速的血液动力学支持,使用血管压缩剂和异型药物来改善心脏输出和保持器官功能. 本综述详细介绍了治疗这种危急疾病的药理策略.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 心脏性休克 (CS) 是一种危及生命的疾病,其特点是循环衰竭和心脏输出不足,导致组织缺氧.
- 及时的血液动力学支持对于预防多器官功能障碍和维持CS患者细胞代谢至关重要.
- 药理疗法,包括血管压缩剂和异型药物,是CS管理的基石,旨在改善输液.
研究的目的:
- 审查目前用于心脏性休克的药物治疗的药理学和血液动力学影响.
- 为这些药物的临床应用提供实用方法.
- 确定对CS的药理血液动力学支持的未来研究方向.
主要方法:
- 对心脏性休克当前药物治疗的文献综述.
- 对血管活性剂的血液动力学影响和作用机制的分析.
- 综合临床实践指南和研究结果.
主要成果:
- 药物制剂,如血管压缩剂和内类药物,对于改善心脏输出和系统性血管抵抗在CS中至关重要.
- 超过90%的CS患者接受至少一种血管活性剂,这强调了药物治疗的重要性.
- 机械循环支持正在引起人们的兴趣,但药物支持仍然是主要的.
结论:
- 药物学血动力学支持对于管理心脏性休克,改善输液和稳定患者至关重要.
- 对于药物药理和血液动力学效应的彻底理解是必要的,以获得最佳的患者结果.
- 需要进一步的研究来完善药理学策略,并探索CS的新疗法.
更多相关视频
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.3K
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
3.7K
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
626
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
626
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
22
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
22
01:22Heart Failure Drugs: β-Blockers
364
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
364
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
01:30Adrenergic Agonists: Therapeutic Uses
843
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
843
01:23Antihypertensive Drugs: Vasodilators
568
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
568